Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    15-October-2000      
Issue 185 Next Update - 14:00 UTC 08:00 EST    16-October-2000            

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya

Proceed To Article In Today's Vidyya
The first nasal vaccine against Alzheimer's disease has been successfully tested in mice.

Proceed To Article Hepatitis C: What Clinicians And Other Health Professionals Need To Know
Hepatitis C: What Clinicians and Other Health Professionals Need to Know is a web-based training course designed to guide clinicians as they face this public health threat. The text is based upon the Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. This Vidyya presents the PDF version of the course provided by the CDC. More...

Proceed To Article 17 African Nations Launch Major Polio Immunization Project
The World Health Organization (WHO) has announced that up to 17 countries in West and Central Africa launched a synchronized polio immunization campaign on October 14 in an attempt to reach 70 million children all at once. More...

Proceed To Article Some Hospitals Shun Drug Used With RU-486, Obstetricians Say Move Is Harmful To Women
Some hospitals have stopped offering a drug that is used in conjunction with the abortion pill RU486. Obstetricians say the result is that women at these hospitals are getting inferior care. More...

Proceed To Article Buprenorphine Update
Most recently, buprenorphine tablets (either buprenorphine alone or the combination with naxolone) were shown in a large clinical trial to be superior to placebo treatment in reducing opiate use. More...

Proceed To Article

Nasal Alzheimer’s Vaccine Successfully Tested in Mice
Nasal administration of synthetic beta amyloid peptide reduces potentially damaging Alzheimer’s disease-like plaques in the brains of test mice and may one day be tested in clinical trials for its ability to vaccinate against plaque formation in people with Alzheimer’s disease (AD), according to a new study by researchers at Harvard Medical School. More...

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.